OpenURL Connection Search

Select item for more details and to access through your institution.

Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.
Published in:
PLoS Pathogens, 2024, v. 20, n. 4, p. 1, doi. 10.1371/journal.ppat.1012132
By:
- Bristol, Jillian A.;
- Nelson, Scott E.;
- Ohashi, Makoto;
- Casco, Alejandro;
- Hayes, Mitchell;
- Ranheim, Erik A.;
- Pawelski, Abigail S.;
- Singh, Deo R.;
- Hodson, Daniel J.;
- Johannsen, Eric C.;
- Kenney, Shannon C.
Publication type:
Article
Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells.
Published in:
PLoS Pathogens, 2022, v. 18, n. 4, p. 1, doi. 10.1371/journal.ppat.1010453
By:
- Bristol, Jillian A.;
- Brand, Joshua;
- Ohashi, Makoto;
- Eichelberg, Mark R.;
- Casco, Alejandro;
- Nelson, Scott E.;
- Hayes, Mitchell;
- Romero-Masters, James C.;
- Baiu, Dana C.;
- Gumperz, Jenny E.;
- Johannsen, Eric C.;
- Dinh, Huy Q.;
- Kenney, Shannon C.
Publication type:
Article
ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells.
Published in:
PLoS Pathogens, 2021, v. 17, n. 11, p. 1, doi. 10.1371/journal.ppat.1010045
By:
- Van Sciver, Nicholas;
- Ohashi, Makoto;
- Nawandar, Dhananjay M.;
- Pauly, Nicholas P.;
- Lee, Denis;
- Makielski, Kathleen R.;
- Bristol, Jillian A.;
- Tsao, Sai Wah;
- Lambert, Paul F.;
- Johannsen, Eric C.;
- Kenney, Shannon C.
Publication type:
Article
Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells.
Published in:
PLoS Pathogens, 2021, v. 17, n. 8, p. 1, doi. 10.1371/journal.ppat.1009783
By:
- Van Sciver, Nicholas;
- Ohashi, Makoto;
- Pauly, Nicholas P.;
- Bristol, Jillian A.;
- Nelson, Scott E.;
- Johannsen, Eric C.;
- Kenney, Shannon C.
Publication type:
Article
An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
Published in:
PLoS Pathogens, 2018, v. 14, n. 8, p. 1, doi. 10.1371/journal.ppat.1007221
By:
- Romero-Masters, James C.;
- Ohashi, Makoto;
- Djavadian, Reza;
- Eichelberg, Mark R.;
- Hayes, Mitch;
- Bristol, Jillian A.;
- Ma, Shidong;
- Ranheim, Erik A.;
- Gumperz, Jenny;
- Johannsen, Eric C.;
- Kenney, Shannon C.
Publication type:
Article
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.
Published in:
PLoS Pathogens, 2018, v. 14, n. 7, p. 1, doi. 10.1371/journal.ppat.1007179
By:
- Bristol, Jillian A.;
- Djavadian, Reza;
- Albright, Emily R.;
- Coleman, Carrie B.;
- Ohashi, Makoto;
- Hayes, Mitchell;
- Romero-Masters, James C.;
- Barlow, Elizabeth A.;
- Farrell, Paul J.;
- Rochford, Rosemary;
- Kalejta, Robert F.;
- Johannsen, Eric C.;
- Kenney, Shannon C.
Publication type:
Article
EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
Published in:
PLoS Pathogens, 2020, v. 16, n. 6, p. 1, doi. 10.1371/journal.ppat.1008590
By:
- Li, Chunrong;
- Romero-Masters, James C.;
- Huebner, Shane;
- Ohashi, Makoto;
- Hayes, Mitchell;
- Bristol, Jillian A.;
- Nelson, Scott E.;
- Eichelberg, Mark R.;
- Van Sciver, Nicholas;
- Ranheim, Erik A.;
- Scott, Rona S.;
- Johannsen, Eric C.;
- Kenney, Shannon C.
Publication type:
Article
B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.
Published in:
PLoS Pathogens, 2020, v. 16, n. 2, p. 1, doi. 10.1371/journal.ppat.1008365
By:
- Romero-Masters, James C.;
- Huebner, Shane M.;
- Ohashi, Makoto;
- Bristol, Jillian A.;
- Benner, Bayleigh E.;
- Barlow, Elizabeth A.;
- Turk, Gail L.;
- Nelson, Scott E.;
- Baiu, Dana C.;
- Van Sciver, Nicholas;
- Ranheim, Erik A.;
- Gumperz, Jenny;
- Sherer, Nathan M.;
- Farrell, Paul J.;
- Johannsen, Eric C.;
- Kenney, Shannon C.
Publication type:
Article
Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes.
Published in:
PLoS Pathogens, 2022, v. 18, n. 10, p. 1, doi. 10.1371/journal.ppat.1010868
By:
- Singh, Deo R.;
- Nelson, Scott E.;
- Pawelski, Abigail S.;
- Cantres-Velez, Juan A.;
- Kansra, Alisha S.;
- Pauly, Nicholas P.;
- Bristol, Jillian A.;
- Hayes, Mitchell;
- Ohashi, Makoto;
- Casco, Alejandro;
- Lee, Denis;
- Fogarty, Stuart A.;
- Lambert, Paul F.;
- Johannsen, Eric C.;
- Kenney, Shannon C.
Publication type:
Article

Found: 9